Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Ursolic Acid Reduces the Metalloprotease/Anti-Metalloprotease Imbalance in Cerebral Ischemia and Reperfusion Injury [Corrigendum]
Received 4 May 2021
Accepted for publication 4 May 2021
Published 11 June 2021 Volume 2021:15 Pages 2483—2484
Wang Y, He Z, Deng S. Drug Des Devel Ther. 2016;10:1663– 1674.
The authors have advised due to an error at the time of figure assembly, Figure 4A on page 1670 is incorrect.
The authors apologize for this error and advise it does not affect the results of the paper.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.